10 Epilepsy (generalized)
10 Hepatocellular carcinoma
10 Leprosy
10 Neuroblastoma
10 Osteoarthritis
10 Psychosis (atypical)
10 Renal cell carcinoma
10 Renal function-related traits (eGRFcrea)
10 Response to antidepressants
10 Response to antipsychotic treatment in schizophrenia (reasoning)
10 Response to cytidine analogues (gemcitabine)
10 Response to fenofibrate
10 Response to inhaled corticosteroid treatment in asthma (percentage change of FEV1)
10 Response to radiotherapy in cancer (late toxicity)
10 Systolic blood pressure in sickle cell anemia
119 Blood pressure
11 Chronic hepatitis B infection
11 Response to antipsychotic treatment in schizophrenia (working memory)
11 Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 1 peripheral neuropathy)
11 Type 1 diabetes nephropathy
122 Bipolar disorder and schizophrenia
122 Inflammatory bowel disease
12 Adverse response to chemotherapy (neutropenia/leucopenia) (all antimicrotubule drugs)
12 Adverse response to lamotrigine and phenytoin
12 Alzheimer's disease (age of onset)
12 Immunoglobulin A
12 Multiple sclerosis (OCB status)
12 Multiple sclerosis (severity)
12 Schizophrenia or bipolar disorder
133 Bipolar disorder
13 Depression (quantitative trait)
13 Endometrial cancer
13 Lung adenocarcinoma
13 Lymphoma
13 Malaria
13 Paget's disease
13 Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 2 peripheral neuropathy)
13 Response to taxane treatment (placlitaxel)
13 Warfarin maintenance dose
142 Cholesterol, total
147 Prostate cancer
14 Esophageal cancer
151 Ulcerative colitis
153 Coronary heart disease
159 Schizophrenia
15 Age-related nuclear cataracts
15 Celiac disease and Rheumatoid arthritis
15 Insulin resistance/response
15 Platelet aggregation
15 Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels)
160 Triglycerides
168 LDL cholesterol
16 Response to anti-retroviral therapy (ddI/d4T) in HIV-1 infection (Grade 3 peripheral neuropathy)
16 Response to taxane treatment (docetaxel)
171 Breast cancer
179 Amyotrophic lateral sclerosis (sporadic)
17 Nasopharyngeal carcinoma
17 Obesity (extreme)
182 Body mass index
182 Multiple sclerosis
18 Basal cell carcinoma 
18 Behcet's disease
18 Breast cancer (early onset)
18 Panic disorder
19 Cardiac hypertrophy
19 Cervical cancer
19 Kawasaki disease
19 Preeclampsia
19 Response to hepatitis C treatment
1 Acute myeloid leukemia
1 Amygdala reactivity
1 Anxiety
1 Autism spectrum disorders (language delay)
1 Breast cancer (estrogen-receptor negative)
1 Breast cancer in BRCA2 mutation carriers
1 Chronic fatigue syndrome
1 Epilepsy
1 CYP3A4 enzyme activity
1 Lupus
1 Neuroblastoma (high-risk)
1 Response to antiplatelet therapy
1 Response to cerivastatin
1 Response to clopidogrel therapy
1 Response to diuretic therapy
1 Response to diuretic therapy in hypertension
1 Response to iloperidone treatment (PANSS-T score)
1 Response to metformin
1 Response to metformin in type 2 diabetes (glycemic)
1 Response to platinum-based chemotherapy in small cell and non-small cell lung cancers
1 Response to platinum-based chemotherapy in small-cell lung cancer
1 Response to radiotherapy in prostate cancer (toxicity)
1 Response to rate control therapy in atrial fibrillation 
1 Response to tamoxifen in breast cancer
1 Response to temozolomide
1 Response to ximelagatran treatment
20 Hypothyroidism
21 Autism
220 Crohn's disease
22 Hodgkin's lymphoma
23 Coronary artery disease
23 Migraine with aura
24 Response to antidepressant treatment
24 Response to citalopram treatment
26 Asthma (childhood onset)
27 Melanoma
29 Endometriosis
29 Ovarian cancer
2 Response to dabigatran etexilate treatment
2 Response to haloperidol in psychosis
2 Response to irinotecan in non-small-cell lung cancer
2 Response to lithium treatment in bipolar disorder
2 Response to methotrexate in rheumatoid arthritis
2 Response to platinum-based chemotherapy in head and neck cancers
31 Telomere length
322 Rheumatoid arthritis
32 Migraine without aura
33 Weight
32 Testicular germ cell tumor
35 Hypertension
36 Lung cancer
38 Breast size
3 Adverse response to chemotherapy in breast cancer (alopecia)
3 Adverse response to chemotherapy in breast cancer (alopecia) (cyclophosphamide+epirubicin+/-5FU)
3 Adverse response to chemotherapy (neutropenia/leucopenia) (camptothecin)
3 Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)
3 Adverse response to chemotherapy (neutropenia/leucopenia) (doxorubicin)
3 Adverse response to radiation therapy
3 Breast cancer (male) 
3 Breast cancer (menopausal hormone therapy interaction)
3 Breast cancer (survival)
3 Diabetes (gestational)
3 IgM levels
3 Insomnia
3 Longevity (90 years and older)
3 Response to antidepressant treatment (citalopram)
3 Response to cholinesterase inhibitors in Alzheimer's disease
3 Response to protease inhibitor treatment in hepatitis c (bilirubin toxicity)
3 Testicular cancer
3 Vitamin D insufficiency
3 Vitamin E levels
41 Pancreatic cancer
44 Acute lymphoblastic leukemia (childhood)
44 Alzheimer's disease (cognitive decline)
44 Longevity
44 Tuberculosis
45 Metabolic syndrome
4 Response to anti-TNF alpha therapy in inflammatory bowel disease
4 Response to interferon beta therapy
4 Response to platinum-based agents
4 Response to protease inhibitor treatment in hepatitis c (peak serum total bilirubin levels)
51 Bipolar disorder (body mass index interaction)
51 Prostate cancer (gene x gene interaction)
522 Height
57 Response to antipsychotic treatment
5 Adverse response to chemotherapy in breast cancer (alopecia) (paclitaxel)
5 Adverse response to chemotherapy (neutropenia/leucopenia) (epirubicin)
5 Adverse response to chemotherapy (neutropenia/leucopenia) (gemcitabine)
5 Asperger disorder
5 Glaucoma
5 Hepatitis B vaccine response
5 Hepatitis C induced liver cirrhosis
5 Response to acetaminophen (hepatotoxicity)
5 Response to angiotensin II receptor blocker therapy (opposite direction w/ diuretic therapy)
5 Response to gemcitabine in pancreatic cancer
5 Response to mTOR inhibitor (rapamycin)
5 Schizophrenia, bipolar disorder and depression (combined)
5 Vitamin D levels
6 Adverse response to chemotherapy (neutropenia/leucopenia) (all anthracycline-based drugs)
6 Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
6 Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)
6 Adverse response to chemotherapy (neutropenia/leucopenia) (all topoisomerase inhibitors)
6 Breast Cancer in BRCA1 mutation carriers
6 Breast cancer (prognosis)
6 Immune reponse to smallpox (secreted IL-10)
6 Immune reponse to smallpox (secreted TNF-alpha)
6 Response to anti-TNF treatment in rheumatoid arthritis
6 Response to iloperidone treatment (QT prolongation)
6 Response to platinum-based chemotherapy in non-small-cell lung cancer
73 Celiac disease
74 Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
75 Phospholipid levels (plasma)
75 Urate levels
76 Migraine
78 Attention deficit hyperactivity disorder
78 Myopia (pathological)
7 Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
7 Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
7 Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
7 Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
7 Adverse response to chemotherapy in breast cancer (alopecia) (anti-microtubule)
7 Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)
7 Adverse response to chemotherapy (neutropenia/leucopenia) (docetaxel)
7 Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)
7 AIDS
7 Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
7 Response to methylphenidate treatment in attention-deficit/hyperactivity disorder (blood pressure)
84 Major depressive disorder
88 Alzheimer's disease
89 Platelet counts
89 Response to amphetamines
